We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

MS Drug Could Reduce Painful Adverse Effects of Cancer Treatment

News   Apr 30, 2018 | Original story from Rockefeller University Press

 
MS Drug Could Reduce Painful Adverse Effects of Cancer Treatment

Compared with control animals (left), the spinal cords of rats treated with bortezomib (center) contain increased numbers of activated astrocytes (green) that cause neuropathic pain. Bortezomib's effects are prevented by the multiple sclerosis drug fingolimod (right), which inhibits the sphingolipid metabolite receptor S1PR1. Credit: Stockstill et al., 2018

 
 
 

RELATED ARTICLES

Practice Makes Your Brain More Efficient, Speeds Up Motor Reaction Times

News

Practicing a movement does make future similar movements happen faster, but not because the brain “anticipates” demand for them.

READ MORE

Molecular Switch May Serve as New Target for Cancer and Diabetes Therapies

News

If certain signaling cascades are misregulated, diseases like cancer, obesity and diabetes may occur. A recently discovered mechanism has a crucial influence on such signaling cascades and may be an important key for the future development of therapies against these diseases.

READ MORE

Possible Reason Why Some People with Brain Markers of Alzheimer’s Don't Have Dementia

News

Why do some people with amyloid plaques and tau tangles typical of symptomatic Alzheimer’s disease, not have dementia?

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE